Alan Lotvin

CIK 1472795 · View on SEC EDGAR ↗

Insider

First SEC filing: July 13, 2022 · Latest: July 13, 2022

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 35 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

35 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 4, 2022 CVS S 10b5-1 22,541 $104.00 $2,344,264 109,183 Direct -17.11% Disposed -9.6% (price as of 2026-08-20)
Aug. 3, 2022 CVS S 10b5-1 50,501 $98.00 $4,949,098 109,183 Direct -31.63% Disposed -4.0% (price as of 2026-08-20)
Aug. 3, 2022 CVS S 10b5-1 70,398 $98.00 $6,899,004 109,183 Direct -39.20% Disposed -4.0% (price as of 2026-08-20)
Feb. 1, 2022 CVS S 10b5-1 21,386 $106.50 $2,277,609 61,341 Direct -25.85% Disposed -11.7% (price as of 2026-08-20)
June 28, 2021 CVS S 10b5-1 2,781 $83.67 $232,686 61,048 Direct -4.36% Disposed 12.4% (price as of 2026-08-20)
Jan. 8, 2021 CVS S 10b5-1 25,836 $75.00 $1,937,700 8,369 Direct -75.53% Disposed 25.4% (price as of 2026-08-20)
Nov. 13, 2020 CVS S 10b5-1 7,138 $70.00 $499,660 8,023 Direct -47.08% Disposed 34.3% (price as of 2026-08-20)
May 11, 2020 CVS P 5,000 $63.14 $315,700 15,161 Direct +49.21% Acquired 48.9% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
May 28, 2026 PROK Director stock option (right to buy) Class A Common Stock (135,000) $1.81 May 28, 2036 135,000 Acquired
May 29, 2025 PROK Director stock option (right to buy) Class A Ordinary Shares (125,862) $0.72 May 29, 2035 125,862 Acquired
May 30, 2024 PROK Director stock option (right to buy) Class A Ordinary Shares (62,558) $4.20 May 30, 2034 62,558 Acquired
June 29, 2023 PROK Director stock option (right to buy) Class A Ordinary Shares (48,128) $10.56 June 29, 2033 48,128 Acquired
Aug. 4, 2022 CVS Stock Option Common Stock (22,541) $62.21 April 1, 2025 22,541 Disposed
Aug. 3, 2022 CVS Stock Option Common Stock (50,501) $54.19 April 1, 2029 50,501 Disposed
Aug. 3, 2022 CVS Stock Option Common Stock (70,398) — April 1, 2030 70,398 Disposed
July 11, 2022 PROK Common Units in ProKidney LP [F3] Class A Ordinary Shares (1,514,326) — — 1,514,326 Acquired
July 11, 2022 PROK Class B Ordinary Shares Class A Ordinary Shares (1,514,326) — — 1,514,326 Acquired
April 1, 2022 CVS Stock Option Common Stock (77,962) $101.09 April 1, 2032 77,962 Acquired
Feb. 1, 2022 CVS Stock Option Common Stock (21,386) $102.26 April 1, 2022 21,386 Disposed
April 1, 2021 CVS Stock Option Common Stock (120,940) $74.30 April 1, 2031 120,940 Acquired
Jan. 8, 2021 CVS Stock Option Common Stock (15,736) $74.29 April 1, 2021 15,736 Disposed
Jan. 8, 2021 CVS Stock Option Common Stock (10,100) $54.19 April 1, 2029 10,100 Disposed
April 1, 2020 CVS Stock Option Common Stock (140,797) — April 1, 2030 140,797 Acquired
April 1, 2020 CVS Stock Option Common Stock (140,797) — April 1, 2030 140,797 Acquired
April 1, 2019 CVS Stock Option Common Stock (80,802) $54.19 April 1, 2029 80,802 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 16 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
July 13, 2022 PROK No securities owned. 0 Direct
June 8, 2018 CVS Common Stock 4,512 Direct
June 8, 2018 CVS Common Stock — Indirect
June 8, 2018 CVS Common Stock (restricted) — Direct
June 8, 2018 CVS Common Stock (restricted) — Direct
June 8, 2018 CVS Common Stock (restricted) — Direct
June 8, 2018 CVS Common Stock (restricted) — Direct
June 8, 2018 CVS Common Stock (restricted) — Direct
June 8, 2018 CVS Common Stock (restricted) — Direct
June 8, 2018 CVS Common Stock (restricted) — Direct
June 8, 2018 CVS Stock Unit — Direct
June 8, 2018 CVS Stock Option→ Common Stock (15,736) 15,736 Direct
June 8, 2018 CVS Stock Option→ Common Stock (21,386) 21,386 Direct
June 8, 2018 CVS Stock Option→ Common Stock (27,395) 27,395 Direct
June 8, 2018 CVS Stock Option→ Common Stock (32,911) 32,911 Direct
June 8, 2018 CVS Stock Option→ Common Stock (22,541) 22,541 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CVS

President and President – Pharmacy Services
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $1,000,000 — $5,624,957 $1,874,986 $2,242,000 — $241,807 $10,983,750
2020 $831,250 — — — $1,577,000 — $83,035 $7,472,175

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.